CEO
Stefano was one of the founders and the director of the Viral Vector Department at Okairos Srl. Previously, Stefano was a senior research fellow at IRBM, where he contributed to drug discovery programs on the hepatitis B and C viruses; and to the adenovirus vector development for therapeutic gene transfer and gene-based vaccination. Stefano has strong research experience in the field of viral vectors for gene delivery and expertise in good manufacturing process (GMP) production and quality assessment. Stefano has overseen and directed manufacturing campaigns of numerous GMP clinical trial materials, and is responsible for the GMP Facility at ReiThera. He has published articles in leading journals such as New England Journal of Medicine and Nature Medicine on viral and infection and vaccines.
Areas of Expertise
Got a Question for Stefano Colloca?
Get in touch using the contact form linked here and we'll get back to you shortly.